Company Filing History:
2 out of 3,539 
1 out of 13 
1 out of 1,217 
Years Active: 1998-2005
Title: Chetan Chitnis: Innovator in Malaria Research
Introduction
Chetan Chitnis is a prominent inventor based in Washington, DC, known for his significant contributions to malaria research. With a total of four patents to his name, he has made strides in developing innovative solutions for the treatment and prevention of malaria.
Latest Patents
Chitnis's latest patents focus on isolated polypeptides derived from the binding domains of Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins. These inventions provide valuable tools in combating malaria, particularly through the use of polypeptides from the EBL family and the sialic acid binding protein (SABP) found on merozoites. Additionally, his work includes polypeptides derived from the Duffy antigen binding protein (DABP) on merozoites, further enhancing the potential for effective malaria treatments.
Career Highlights
Throughout his career, Chetan Chitnis has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services. His role in these institutions has allowed him to contribute significantly to public health and scientific research.
Collaborations
Chitnis has collaborated with notable colleagues such as Kim Lee Sim and Louis H Miller, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Chetan Chitnis stands out as an influential inventor in the field of malaria research, with a focus on innovative polypeptide solutions. His work continues to pave the way for advancements in the treatment and prevention of this critical disease.